504 related articles for article (PubMed ID: 16932226)
1. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
[TBL] [Abstract][Full Text] [Related]
4. Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.
Asakura H; Sano Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Haematologica; 2004 Jun; 89(6):757-8. PubMed ID: 15194548
[TBL] [Abstract][Full Text] [Related]
5. Effect of FC43se on endotoxin-induced disseminated intravascular coagulation in rats.
Ochikubo H; Wada S; Sugawara Y; Sueda T; Matsuura Y
Hiroshima J Med Sci; 1999 Jun; 48(2):71-7. PubMed ID: 10434477
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
[TBL] [Abstract][Full Text] [Related]
7. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
8. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
9. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats.
Asakura H; Suga Y; Aoshima K; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Takami A; Miyamoto K; Nakao S
Crit Care Med; 2002 Jan; 30(1):161-4. PubMed ID: 11902257
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
11. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
Chai J; Wu Y; Sheng ZZ
Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
[TBL] [Abstract][Full Text] [Related]
12. Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats.
Asakura H; Okudaira M; Yoshida T; Ontachi Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Thromb Haemost; 2002 Oct; 88(4):663-7. PubMed ID: 12362240
[TBL] [Abstract][Full Text] [Related]
13. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
15. Plasma level of IL-1 beta in disseminated intravascular coagulation.
Wada H; Tamaki S; Tanigawa M; Takagi M; Mori Y; Deguchi A; Katayama N; Yamamoto T; Deguchi K; Shirakawa S
Thromb Haemost; 1991 Apr; 65(4):364-8. PubMed ID: 2057918
[TBL] [Abstract][Full Text] [Related]
16. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
17. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
[TBL] [Abstract][Full Text] [Related]
18. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.
Wang B; Wu SM; Wang T; Liu K; Zhang G; Zhang XQ; Yu JH; Liu CZ; Fang CC
Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895
[TBL] [Abstract][Full Text] [Related]
20. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
